 | • レポートコード：GIR-107A01055 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、80ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学＆材料 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、筋肉内免疫グロブリンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。筋肉内免疫グロブリンの種類別市場規模（10mLバイアル、2.0mLバイアル）、用途別市場規模（A型肝炎、はしか、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・筋肉内免疫グロブリンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Grifols Therapeutics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：10mLバイアル、2.0mLバイアル ・用途別分析2016年-2026年：A型肝炎、はしか、その他 ・筋肉内免疫グロブリンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・筋肉内免疫グロブリンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・筋肉内免疫グロブリンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・筋肉内免疫グロブリンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・筋肉内免疫グロブリンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Intramuscular Immune Globulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Intramuscular Immune Globulin size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Intramuscular Immune Globulin market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Intramuscular Immune Globulin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
10mL Vial
2.0mL Vial
Market segment by Application can be divided into
Hepatitis A
Measles
Others
The key market players for global Intramuscular Immune Globulin market are listed below:
Grifols Therapeutics
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Intramuscular Immune Globulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intramuscular Immune Globulin, with price, sales, revenue and global market share of Intramuscular Immune Globulin from 2019 to 2021.
Chapter 3, the Intramuscular Immune Globulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intramuscular Immune Globulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Intramuscular Immune Globulin market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Intramuscular Immune Globulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Intramuscular Immune Globulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Intramuscular Immune Globulin Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 10mL Vial
1.2.3 2.0mL Vial
1.3 Market Analysis by Application
1.3.1 Overview: Global Intramuscular Immune Globulin Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hepatitis A
1.3.3 Measles
1.3.4 Others
1.4 Global Intramuscular Immune Globulin Market Size & Forecast
1.4.1 Global Intramuscular Immune Globulin Sales in Value (2016-2026))
1.4.2 Global Intramuscular Immune Globulin Sales in Volume (2016-2026)
1.4.3 Global Intramuscular Immune Globulin Price by Type (2016-2026) & (US$/Ton)
1.5 Global Intramuscular Immune Globulin Production Capacity Analysis
1.5.1 Global Intramuscular Immune Globulin Total Production Capacity (2016-2026)
1.5.2 Global Intramuscular Immune Globulin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Intramuscular Immune Globulin Market Drivers
1.6.2 Intramuscular Immune Globulin Market Restraints
1.6.3 Intramuscular Immune Globulin Trends Analysis
2 Manufacturers Profiles
2.1 Grifols Therapeutics
2.1.1 Grifols Therapeutics Details
2.1.2 Grifols Therapeutics Major Business
2.1.3 Grifols Therapeutics Intramuscular Immune Globulin Product and Services
2.1.4 Grifols Therapeutics Intramuscular Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Intramuscular Immune Globulin Sales by Manufacturer
3.1 Global Intramuscular Immune Globulin Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Intramuscular Immune Globulin Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Intramuscular Immune Globulin
3.4 Market Concentration Rate
3.4.1 Top 3 Intramuscular Immune Globulin Manufacturer Market Share
3.4.2 Top 6 Intramuscular Immune Globulin Manufacturer Market Share
3.5 Global Intramuscular Immune Globulin Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Intramuscular Immune Globulin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Intramuscular Immune Globulin Market Size by Region
4.1.1 Global Intramuscular Immune Globulin Sales in Volume by Region (2016-2026)
4.1.2 Global Intramuscular Immune Globulin Revenue by Region (2016-2026)
4.2 North America Intramuscular Immune Globulin Revenue (2016-2026)
4.3 Europe Intramuscular Immune Globulin Revenue (2016-2026)
4.4 Asia-Pacific Intramuscular Immune Globulin Revenue (2016-2026)
4.5 South America Intramuscular Immune Globulin Revenue (2016-2026)
4.6 Middle East and Africa Intramuscular Immune Globulin Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Intramuscular Immune Globulin Sales in Volume by Type (2016-2026)
5.2 Global Intramuscular Immune Globulin Revenue by Type (2016-2026)
5.3 Global Intramuscular Immune Globulin Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Intramuscular Immune Globulin Sales in Volume by Application (2016-2026)
6.2 Global Intramuscular Immune Globulin Revenue by Application (2016-2026)
6.3 Global Intramuscular Immune Globulin Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Intramuscular Immune Globulin Sales by Type (2016-2026)
7.2 North America Intramuscular Immune Globulin Sales by Application (2016-2026)
7.3 North America Intramuscular Immune Globulin Market Size by Country
7.3.1 North America Intramuscular Immune Globulin Sales in Volume by Country (2016-2026)
7.3.2 North America Intramuscular Immune Globulin Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Intramuscular Immune Globulin Sales by Type (2016-2026)
8.2 Europe Intramuscular Immune Globulin Sales by Application (2016-2026)
8.3 Europe Intramuscular Immune Globulin Market Size by Country
8.3.1 Europe Intramuscular Immune Globulin Sales in Volume by Country (2016-2026)
8.3.2 Europe Intramuscular Immune Globulin Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Intramuscular Immune Globulin Sales by Type (2016-2026)
9.2 Asia-Pacific Intramuscular Immune Globulin Sales by Application (2016-2026)
9.3 Asia-Pacific Intramuscular Immune Globulin Market Size by Region
9.3.1 Asia-Pacific Intramuscular Immune Globulin Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Intramuscular Immune Globulin Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Intramuscular Immune Globulin Sales by Type (2016-2026)
10.2 South America Intramuscular Immune Globulin Sales by Application (2016-2026)
10.3 South America Intramuscular Immune Globulin Market Size by Country
10.3.1 South America Intramuscular Immune Globulin Sales in Volume by Country (2016-2026)
10.3.2 South America Intramuscular Immune Globulin Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Intramuscular Immune Globulin Sales by Type (2016-2026)
11.2 Middle East & Africa Intramuscular Immune Globulin Sales by Application (2016-2026)
11.3 Middle East & Africa Intramuscular Immune Globulin Market Size by Country
11.3.1 Middle East & Africa Intramuscular Immune Globulin Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Intramuscular Immune Globulin Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Intramuscular Immune Globulin Typical Distributors
12.3 Intramuscular Immune Globulin Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Intramuscular Immune Globulin Revenue by Type, (USD Million), 2021-2026
Table 2. Global Intramuscular Immune Globulin Revenue by Application, (USD Million), 2021-2026
Table 3. Grifols Therapeutics Basic Information, Manufacturing Base and Competitors
Table 4. Grifols Therapeutics Major Business
Table 5. Grifols Therapeutics Intramuscular Immune Globulin Product and Services
Table 6. Grifols Therapeutics Intramuscular Immune Globulin Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Global Intramuscular Immune Globulin Sales by Manufacturer (2019-2021e) & (Kiloton)
Table 8. Global Intramuscular Immune Globulin Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 9. Market Position of Manufacturers in Intramuscular Immune Globulin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 10. Global Intramuscular Immune Globulin Production Capacity by Company, (Kiloton): 2020 VS 2021
Table 11. Head Office and Intramuscular Immune Globulin Production Site of Key Manufacturer
Table 12. Intramuscular Immune Globulin New Entrant and Capacity Expansion Plans
Table 13. Intramuscular Immune Globulin Mergers & Acquisitions in the Past Five Years
Table 14. Global Intramuscular Immune Globulin Sales by Region (2016-2021e) & (Kiloton)
Table 15. Global Intramuscular Immune Globulin Sales by Region (2021-2026) & (Kiloton)
Table 16. Global Intramuscular Immune Globulin Revenue by Region (2016-2021e) & (USD Million)
Table 17. Global Intramuscular Immune Globulin Revenue by Region (2021-2026) & (USD Million)
Table 18. Global Intramuscular Immune Globulin Sales by Type (2016-2021e) & (Kiloton)
Table 19. Global Intramuscular Immune Globulin Sales by Type (2021-2026) & (Kiloton)
Table 20. Global Intramuscular Immune Globulin Revenue by Type (2016-2021e) & (USD Million)
Table 21. Global Intramuscular Immune Globulin Revenue by Type (2021-2026) & (USD Million)
Table 22. Global Intramuscular Immune Globulin Price by Type (2016-2021e) & (US$/Ton)
Table 23. Global Intramuscular Immune Globulin Price by Type (2021-2026) & (US$/Ton)
Table 24. Global Intramuscular Immune Globulin Sales by Application (2016-2021e) & (Kiloton)
Table 25. Global Intramuscular Immune Globulin Sales by Application (2021-2026) & (Kiloton)
Table 26. Global Intramuscular Immune Globulin Revenue by Application (2016-2021e) & (USD Million)
Table 27. Global Intramuscular Immune Globulin Revenue by Application (2021-2026) & (USD Million)
Table 28. Global Intramuscular Immune Globulin Price by Application (2016-2021e) & (US$/Ton)
Table 29. Global Intramuscular Immune Globulin Price by Application (2021-2026) & (US$/Ton)
Table 30. North America Intramuscular Immune Globulin Sales by Country (2016-2021e) & (Kiloton)
Table 31. North America Intramuscular Immune Globulin Sales by Country (2021-2026) & (Kiloton)
Table 32. North America Intramuscular Immune Globulin Revenue by Country (2016-2021e) & (USD Million)
Table 33. North America Intramuscular Immune Globulin Revenue by Country (2021-2026) & (USD Million)
Table 34. North America Intramuscular Immune Globulin Sales by Type (2016-2021e) & (Kiloton)
Table 35. North America Intramuscular Immune Globulin Sales by Type (2021-2026) & (Kiloton)
Table 36. North America Intramuscular Immune Globulin Sales by Application (2016-2021e) & (Kiloton)
Table 37. North America Intramuscular Immune Globulin Sales by Application (2021-2026) & (Kiloton)
Table 38. Europe Intramuscular Immune Globulin Sales by Country (2016-2021e) & (Kiloton)
Table 39. Europe Intramuscular Immune Globulin Sales by Country (2021-2026) & (Kiloton)
Table 40. Europe Intramuscular Immune Globulin Revenue by Country (2016-2021e) & (USD Million)
Table 41. Europe Intramuscular Immune Globulin Revenue by Country (2021-2026) & (USD Million)
Table 42. Europe Intramuscular Immune Globulin Sales by Type (2016-2021e) & (Kiloton)
Table 43. Europe Intramuscular Immune Globulin Sales by Type (2021-2026) & (Kiloton)
Table 44. Europe Intramuscular Immune Globulin Sales by Application (2016-2021e) & (Kiloton)
Table 45. Europe Intramuscular Immune Globulin Sales by Application (2021-2026) & (Kiloton)
Table 46. Asia-Pacific Intramuscular Immune Globulin Sales by Region (2016-2021e) & (Kiloton)
Table 47. Asia-Pacific Intramuscular Immune Globulin Sales by Region (2021-2026) & (Kiloton)
Table 48. Asia-Pacific Intramuscular Immune Globulin Revenue by Region (2016-2021e) & (USD Million)
Table 49. Asia-Pacific Intramuscular Immune Globulin Revenue by Region (2021-2026) & (USD Million)
Table 50. Asia-Pacific Intramuscular Immune Globulin Sales by Type (2016-2021e) & (Kiloton)
Table 51. Asia-Pacific Intramuscular Immune Globulin Sales by Type (2021-2026) & (Kiloton)
Table 52. Asia-Pacific Intramuscular Immune Globulin Sales by Application (2016-2021e) & (Kiloton)
Table 53. Asia-Pacific Intramuscular Immune Globulin Sales by Application (2021-2026) & (Kiloton)
Table 54. South America Intramuscular Immune Globulin Sales by Country (2016-2021e) & (Kiloton)
Table 55. South America Intramuscular Immune Globulin Sales by Country (2021-2026) & (Kiloton)
Table 56. South America Intramuscular Immune Globulin Revenue by Country (2016-2021e) & (USD Million)
Table 57. South America Intramuscular Immune Globulin Revenue by Country (2021-2026) & (USD Million)
Table 58. South America Intramuscular Immune Globulin Sales by Type (2016-2021e) & (Kiloton)
Table 59. South America Intramuscular Immune Globulin Sales by Type (2021-2026) & (Kiloton)
Table 60. South America Intramuscular Immune Globulin Sales by Application (2016-2021e) & (Kiloton)
Table 61. South America Intramuscular Immune Globulin Sales by Application (2021-2026) & (Kiloton)
Table 62. Middle East & Africa Intramuscular Immune Globulin Sales by Country (2016-2021e) & (Kiloton)
Table 63. Middle East & Africa Intramuscular Immune Globulin Sales by Country (2021-2026) & (Kiloton)
Table 64. Middle East & Africa Intramuscular Immune Globulin Revenue by Country (2016-2021e) & (USD Million)
Table 65. Middle East & Africa Intramuscular Immune Globulin Revenue by Country (2021-2026) & (USD Million)
Table 66. Middle East & Africa Intramuscular Immune Globulin Sales by Type (2016-2021e) & (Kiloton)
Table 67. Middle East & Africa Intramuscular Immune Globulin Sales by Type (2021-2026) & (Kiloton)
Table 68. Middle East & Africa Intramuscular Immune Globulin Sales by Application (2016-2021e) & (Kiloton)
Table 69. Middle East & Africa Intramuscular Immune Globulin Sales by Application (2021-2026) & (Kiloton)
Table 70. Direct Channel Pros & Cons
Table 71. Indirect Channel Pros & Cons
Table 72. Intramuscular Immune Globulin Typical Distributors
Table 73. Intramuscular Immune Globulin Typical Customers
List of Figures
Figure 1. Intramuscular Immune Globulin Picture
Figure 2. Global Intramuscular Immune Globulin Sales Market Share by Type in 2020
Figure 3. 10mL Vial
Figure 4. 2.0mL Vial
Figure 5. Global Intramuscular Immune Globulin Sales Market Share by Application in 2020
Figure 6. Hepatitis A
Figure 7. Measles
Figure 8. Others
Figure 9. Global Intramuscular Immune Globulin Market Size, (USD Million) & (Kiloton): 2020 VS 2021 VS 2026
Figure 10. Global Intramuscular Immune Globulin Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Intramuscular Immune Globulin Sales (2016-2026) & (Kiloton)
Figure 12. Global Intramuscular Immune Globulin Price by Type (2016-2026) & (US$/Ton)
Figure 13. Global Intramuscular Immune Globulin Production Capacity (2016-2026) & (Kiloton)
Figure 14. Global Intramuscular Immune Globulin Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Intramuscular Immune Globulin Market Drivers
Figure 16. Intramuscular Immune Globulin Market Restraints
Figure 17. Intramuscular Immune Globulin Market Trends
Figure 18. Global Intramuscular Immune Globulin Sales Market Share by Manufacturer in 2020
Figure 19. Global Intramuscular Immune Globulin Revenue Market Share by Manufacturer in 2020
Figure 20. Intramuscular Immune Globulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Intramuscular Immune Globulin Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Intramuscular Immune Globulin Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Intramuscular Immune Globulin Sales Market Share by Region (2016-2026)
Figure 24. Global Intramuscular Immune Globulin Revenue Market Share by Region (2016-2026)
Figure 25. North America Intramuscular Immune Globulin Revenue (2016-2026) & (USD Million)
Figure 26. Europe Intramuscular Immune Globulin Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Intramuscular Immune Globulin Revenue (2016-2026) & (USD Million)
Figure 28. South America Intramuscular Immune Globulin Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Intramuscular Immune Globulin Revenue (2016-2026) & (USD Million)
Figure 30. Global Intramuscular Immune Globulin Sales Market Share by Type (2016-2026)
Figure 31. Global Intramuscular Immune Globulin Revenue Market Share by Type (2016-2026)
Figure 32. Global Intramuscular Immune Globulin Price by Type (2016-2026) & (US$/Ton)
Figure 33. Global Intramuscular Immune Globulin Sales Market Share by Application (2016-2026)
Figure 34. Global Intramuscular Immune Globulin Revenue Market Share by Application (2016-2026)
Figure 35. Global Intramuscular Immune Globulin Price by Application (2016-2026) & (US$/Ton)
Figure 36. North America Intramuscular Immune Globulin Sales Market Share by Type (2016-2026)
Figure 37. North America Intramuscular Immune Globulin Sales Market Share by Application (2016-2026)
Figure 38. North America Intramuscular Immune Globulin Sales Market Share by Country (2016-2026)
Figure 39. North America Intramuscular Immune Globulin Revenue Market Share by Country (2016-2026)
Figure 40. United States Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Intramuscular Immune Globulin Sales Market Share by Type (2016-2026)
Figure 44. Europe Intramuscular Immune Globulin Sales Market Share by Application (2016-2026)
Figure 45. Europe Intramuscular Immune Globulin Sales Market Share by Country (2016-2026)
Figure 46. Europe Intramuscular Immune Globulin Revenue Market Share by Country (2016-2026)
Figure 47. Germany Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Intramuscular Immune Globulin Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Intramuscular Immune Globulin Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Intramuscular Immune Globulin Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Intramuscular Immune Globulin Revenue Market Share by Region (2016-2026)
Figure 56. China Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Intramuscular Immune Globulin Sales Market Share by Type (2016-2026)
Figure 63. South America Intramuscular Immune Globulin Sales Market Share by Application (2016-2026)
Figure 64. South America Intramuscular Immune Globulin Sales Market Share by Country (2016-2026)
Figure 65. South America Intramuscular Immune Globulin Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Intramuscular Immune Globulin Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Intramuscular Immune Globulin Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Intramuscular Immune Globulin Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Intramuscular Immune Globulin Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Intramuscular Immune Globulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の動物由来免疫グロブリン市場 2021：企業別、地域別、種類・用途別 The Animal-derived Immune Globulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …- 動物免疫グロブリン製品市場：世界及び中国市場分析・予測（～2024年） Animal-derived Immune Globulin Products Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Animal-derived Immune Globulin Products industry with a focus on the Chinese market. The report provides key statistics on the market stat…
- 世界の静脈内免疫グロブリン療法市場予測（～2024年） Immune globulin derived from the plasma of paid and volunteer donors is used in the treatment of an array of disorders, including primary and secondary immune deficiency states and a variety of autoimmune and inflammatory disorders. Scope of the Report: The global Intravenous Immune Globulin Therapi…
- 免疫分析システム市場：世界及び中国市場分析・予測（～2024年） Immune Analysis System Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Immune Analysis System industry with a focus on the Chinese market. The report provides key statistics on the market status of the Immune Analysis System m…
- 免疫性血小板減少薬の世界市場… Scope of the Report: The global Immune Thrombocytopenia Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Ch…